...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Additional Exempt Distribution
Reply New Message
Prev Message Back To Forum Threaded View Next Message

would add. I haven't been & will not buy or sell a share in either of these companies & would recommend the same to others until Don is removed and or we see a clear solid concrete path forward

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply